Mylan NVs EpiPen Product Illustrations As Company's Move to Curb EpiPen Costs Blasted as PR Fix by Congress

A Mylan NV EpiPen allergy shot sits on display for a photograph in Princeton, Illinois, U.S., on Friday, Aug. 26, 2016. In response to intense criticism over the past few days, Mylan NV moved Thursday to expand assistance programs that help patients with high out-of-pocket expenses -- but didn't go as far as cutting the treatment's list price. Health insurers and U.S. lawmakers criticized the effort as an attempt to cover a 400 percent price hike that won't make the drug more affordable. Photographer: Daniel Acker/Bloomberg via Getty Images

Mylan NVs EpiPen Product Illustrations As Company's Move to Curb EpiPen Costs Blasted as PR Fix by Congress
A Mylan NV EpiPen allergy shot sits on display for a photograph in Princeton, Illinois, U.S., on Friday, Aug. 26, 2016. In response to intense criticism over the past few days, Mylan NV moved Thursday to expand assistance programs that help patients with high out-of-pocket expenses -- but didn't go as far as cutting the treatment's list price. Health insurers and U.S. lawmakers criticized the effort as an attempt to cover a 400 percent price hike that won't make the drug more affordable. Photographer: Daniel Acker/Bloomberg via Getty Images
ACHETER UNE LICENCE
Comment puis-je utiliser cette image ?
385,00 €
EUR
Getty ImagesMylan NVs EpiPen Product Illustrations As Company's Move to Curb..., Photo d'actualitéMylan NVs EpiPen Product Illustrations As Company's Move to Curb..., Photo d'actualitéMylan NVs EpiPen Product Illustrations As Company's Move to Curb... Obtenez des photos d'actualité haute résolution de qualité sur Getty ImagesProduct #:595921824
475€175€
Getty Images
In stock

INFORMATIONS

Restrictions :
Contactez votre agence locale pour toute utilisation commerciale ou promotionnelle.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Crédits :
Bloomberg / Contributeur
Editorial - n° :
595921824
Collection :
Bloomberg
Date de création :
26 août 2016
Date de chargement :
Type de licence :
Droits gérés
Infos autorisations :
Autorisation non disponible. Plus d'infos
Source :
Bloomberg
Référence :
MYLAN EPIPEN
Taille max. de fichier :
4000 x 2667 px (33,87 x 22,58 cm) - 300 dpi - 3 MB